Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

US9987266B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Ryan M. Moslin · Princeton, US
• David S. Weinstein · Plainsboro, US
• Stephen T. Wrobleski · Whitehouse Station, US
• Yanlei Zhang · Princeton, US
• John S. Tokarski · Princeton, US
• Michael E. Mertzman · New Hope, US
• Chunjian Liu · Pennington, US

Key dates

• Filing date: Apr 6, 2017
• Grant date: Jun 5, 2018
• Expiry date: Apr 6, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D213/56
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds having the following formula I: or a stereoisomer or a pharmaceutically-acceptable salt thereof, wherein R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα by acting on Tyk-2 to cause signal transduction inhibition.